Samir Gharib
Director of Finance/CFO at SPRUCE BIOSCIENCES, INC.
Net worth: 150 257 $ as of 31/05/2024
Samir Gharib active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Director of Finance/CFO | 01/05/2020 | - |
| President | 01/01/2022 | - | |
| Cancer CAREpoint | Director/Board Member | 01/11/2017 | - |
Career history of Samir Gharib
Former positions of Samir Gharib
| Companies | Position | Start | End |
|---|---|---|---|
Stemedica Cell Technologies, Inc.
 Stemedica Cell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Stemedica Cell Technologies, Inc. operates as a biotechnology company that manufactures adult allergenic stem cells. Its adult stem cells which are used by research institutions and hospitals for pre-clinical and clinical studies. It has offices in Mexico, Italy, Switzerland, and France. The company was founded by Roger J. Howe and Maynard A. Howe in 2005 and is headquartered in San Diego, CA. | Director of Finance/CFO | 01/10/2018 | 01/09/2019 |
| Benchmark Financial Partners LLC | Corporate Officer/Principal | 01/09/2017 | 01/10/2018 |
| REVANCE THERAPEUTICS, INC. | Chief Administrative Officer | 01/10/2013 | 01/09/2017 |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Comptroller/Controller/Auditor | 01/01/2011 | 01/09/2013 |
Training of Samir Gharib
| Haas School of Business | Undergraduate Degree |
Statistics
International
| United States | 8 |
Operational
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| REVANCE THERAPEUTICS, INC. | Health Technology |
| SPRUCE BIOSCIENCES, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Health Technology |
Stemedica Cell Technologies, Inc.
Stemedica Cell Technologies, Inc. Pharmaceuticals: MajorHealth Technology Stemedica Cell Technologies, Inc. operates as a biotechnology company that manufactures adult allergenic stem cells. Its adult stem cells which are used by research institutions and hospitals for pre-clinical and clinical studies. It has offices in Mexico, Italy, Switzerland, and France. The company was founded by Roger J. Howe and Maynard A. Howe in 2005 and is headquartered in San Diego, CA. | Health Technology |
| Cancer CAREpoint | |
| Benchmark Financial Partners LLC |
- Stock Market
- Insiders
- Samir Gharib
- Experience
